Evaluation of Clinical Efficacy of Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma: a Prospective Multicenter Study

Seoul National University Hospital1 site in 1 country159 target enrollmentApril 5, 2021

ConditionsHepatocellular Carcinoma (HCC)

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hepatocellular Carcinoma (HCC)
Sponsor: Seoul National University Hospital
Enrollment: 159
Locations: 1
Primary Endpoint: Estimated local tumor progression rate
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate, through a prospective multicenter trial, the procedural time, safety, technical success rate for achieving a safety margin of at least 5 mm around the tumor, and the clinical efficacy (local and remote recurrence rates: estimated local recurrence rate at 12 months) of radiofrequency ablation using the "No-touch" technique. This approach employs Octopus electrodes and combined radiofrequency energy delivery (dual switching monopolar and bipolar mode) for the treatment of hepatocellular carcinoma.

Registry

clinicaltrials.gov

Start Date

April 5, 2021

End Date

December 30, 2025

Last Updated

last year

Study Type

Interventional

Study Design

Single Group